 Counsel & Heal | Adding rituximab helps treat mediastinal B-cell lymphoma Curetoday.com (press release) NEW YORK (Reuters Health) - A phase II trial in patients with primary mediastinal B-cell lymphoma has found that rituximab can improve the effectiveness of a six-drug anti-cancer cocktail, nearly eliminating the need for radiotherapy. The five-year ... NIH trial shows promising results in treating a lymphoma in young people Chemotherapy, no radiation for lymphoma type effective New Treatment For Lymphoma May Mean Skipping Radiation |
